Try our Advanced Search for more refined results
January 28, 2020
Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. et al
Case Number:
1:20-cv-00133
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
- McCarter & English
- Morris James
- Phillips McLaughlin
- Pinckney Weidinger
- Potter Anderson
- Stamoulis & Weinblatt
- Young Conaway
Companies
- Apotex Inc.
- Avet Pharmaceuticals Inc.
- BionPharma Inc.
- Emcure Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd.
- Prinston Pharmaceutical Inc.
- Zydus Pharmaceuticals Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 02, 2020
Hetero, Zydus Settle Novartis MS Drug Suits Before IP Trial
Generic-drug makers Hetero and Zydus have each reached last-minute settlements to avoid an infringement trial set for Monday over their versions of Novartis Pharmaceuticals Corp.'s blockbuster multiple sclerosis drug Gilenya.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login